Alembic Pharma announces U.S. FDA approval for Dabigatran Etexilate Capsules, 75 mg and 150 mg and tentative approval for Dabigatran Etexilate Capsules, 110 mg Read more
Wanbury’s Patalganga manufacturing facility clears U.S. FDA inspection with zero observations Read more
FDA approved KEYTRUDA in combination with chemotherapy for adult patients with endometrial carcinoma Read more
Alembic Pharma announces USFDA final approval for Icatibant injection, 30 mg/3 mL (10 mg/mL) single-dose prefilled syringe Read more